The meeting will be set-up as a non-profit event by the European Bioanalysis Forum (EBF) in collaboration with Bavalan Bioconference SARL.
MEETING ORGANISATION - SCIENTIFIC CONTENT OF MEETING
- Richard Abbott, Shire, United Kingdom
- Michaela Golob, Merck-Serono, Germany
- Silke Luedtke, Boehringer Ingelheim, Germany
- Elizabeth Thomas, AstraZeneca, United Kingdom
- Margarete Brudny-Kloeppel, Bayer Schering Pharma AG, Germany
- Berthold Lausecker, F Hoffmann-La Roche Ltd, Switzerland
- Philip Timmerman, Johnson&Johnson, Belgium
- Peter van Amsterdam, Abbott, Netherlands
- Christian Herling, NovoNordisk, Denmark
- Magnus Knutsson, Ferring, Denmark
EBF
BAVALAN BIOCONFERENCE / Christina Smith
|
|